标题
Dendritic cell-based immunotherapy in mesothelioma
作者
关键词
-
出版物
Immunotherapy
Volume 4, Issue 10, Pages 1011-1022
出版商
Future Medicine Ltd
发表日期
2012-11-14
DOI
10.2217/imt.12.108
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A multicenter, randomized phase III maintenance study of thalidomide (arm A) versus observation (arm B) in patients with malignant pleural mesothelioma (MPM) after induction chemotherapy.
- (2017) P. Baas et al. JOURNAL OF CLINICAL ONCOLOGY
- Defective MHC Class II Presentation by Dendritic Cells Limits CD4 T Cell Help for Antitumor CD8 T Cell Responses
- (2014) M. Y. Gerner et al. JOURNAL OF IMMUNOLOGY
- Human dendritic cells sequentially matured with CD4+ T cells as a secondary signal favor CTL and long-term T memory cell responses
- (2012) Thomas Simon et al. BIOLOGICAL RESEARCH
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10–producing suppressive CD4+T cells
- (2012) Dapeng Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Pleurectomy/Decortication is Superior to Extrapleural Pneumonectomy in the Multimodality Management of Patients with Malignant Pleural Mesothelioma
- (2012) Loïc Lang-Lazdunski et al. Journal of Thoracic Oncology
- A Trial of Intrapleural Adenoviral-mediated Interferon-α2b Gene Transfer for Malignant Pleural Mesothelioma
- (2011) Daniel H. Sterman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling
- (2011) D. A. Hume et al. BLOOD
- Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma
- (2011) Bryan M. Burt et al. CANCER
- Review on clinical trials of targeted treatments in malignant mesothelioma
- (2011) Jan Nyrop Jakobsen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma
- (2011) Adam J. Bograd et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma
- (2011) H. Murakami et al. CANCER RESEARCH
- Asbestos Induces Reduction of Tumor Immunity
- (2011) Naoko Kumagai-Takei et al. Clinical & Developmental Immunology
- The Dendritic Cell-Regulatory T Lymphocyte Crosstalk Contributes to Tumor-Induced Tolerance
- (2011) Nona Janikashvili et al. Clinical & Developmental Immunology
- Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
- (2011) Jermaine Coward et al. CLINICAL CANCER RESEARCH
- Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma
- (2011) Antonia Busse et al. EUROPEAN JOURNAL OF CANCER
- Iron as a target of chemoprevention for longevity in humans
- (2011) Shinya Toyokuni FREE RADICAL RESEARCH
- The European Multidisciplinary Cancer Congress (ECCO 16, ESMO 36 and ESTRO 30)
- (2011) Camillo Porta Future Oncology
- Dendritic cells, dendritic cell-based vaccines and Ralph Steinman
- (2011) Hans-Gustaf Ljunggren JOURNAL OF INTERNAL MEDICINE
- Identification and manipulation of tumor associated macrophages in human cancers
- (2011) Moniek Heusinkveld et al. Journal of Translational Medicine
- Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation
- (2011) Yoshitaka Sekido PATHOLOGY INTERNATIONAL
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines
- (2011) Paul J. Tacken et al. SEMINARS IN IMMUNOLOGY
- Intrathoracic chemo-thermotherapy with radiofrequency waves after extrapleural pneumonectomy for malignant pleural mesothelioma
- (2011) T. Tokunaga et al. Interactive Cardiovascular and Thoracic Surgery
- Consolidative Dendritic Cell-based Immunotherapy Elicits Cytotoxicity against Malignant Mesothelioma
- (2010) Joost P. Hegmans et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
- (2010) Joris D Veltman et al. BMC CANCER
- Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma
- (2010) J D Veltman et al. BRITISH JOURNAL OF CANCER
- Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
- (2010) Y. Zhao et al. CANCER RESEARCH
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Tumor Antigen Cross-Presentation and the Dendritic Cell: Where it All Begins?
- (2010) Alison M. McDonnell et al. Clinical & Developmental Immunology
- Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers
- (2010) R. Hassan et al. CLINICAL CANCER RESEARCH
- Targeting immune suppressing myeloid-derived suppressor cells in oncology
- (2010) Johnny Kao et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- CD8α+ DC are not the sole subset cross-presenting cell-associated tumor antigens from a solid tumor
- (2010) Alison M. McDonnell et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Origin and development of dendritic cells
- (2010) Kang Liu et al. IMMUNOLOGICAL REVIEWS
- Histone Deacetylase Inhibitors in Malignant Pleural Mesothelioma: Preclinical Rationale and Clinical Trials
- (2010) Paul K. Paik et al. Journal of Thoracic Oncology
- A Phase II Study of Sorafenib in Malignant Mesothelioma: Results of Cancer and Leukemia Group B 30307
- (2010) Sarita Dubey et al. Journal of Thoracic Oncology
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma
- (2010) Jason M Foster et al. World Journal of Surgical Oncology
- What's the place of immunotherapy in malignant mesothelioma treatments?
- (2010) Marc Grégoire Cell Adhesion & Migration
- Dendritic cell vaccination as a treatment modality for mesothelioma
- (2010) Marc Gregoire Expert Review of Respiratory Medicine
- CCL2 Blockade Augments Cancer Immunotherapy
- (2009) Z. G. Fridlender et al. CANCER RESEARCH
- Role of iron in carcinogenesis: Cancer as a ferrotoxic disease
- (2009) Shinya Toyokuni CANCER SCIENCE
- Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P
- (2009) R. J. Kreitman et al. CLINICAL CANCER RESEARCH
- Recent advances in antigen-loaded dendritic cell-based strategies for treatment of minimal residual disease in acute myeloid leukemia
- (2009) Willemijn van den Ancker et al. Immunotherapy
- Directing dendritic cell immunotherapy towards successful cancer treatment
- (2009) Rachel Lubong Sabado et al. Immunotherapy
- Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
- (2009) G. Solinas et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
- (2009) C. Carpenito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma
- (2008) Masaki Anraku et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
- (2008) C. Dostert et al. SCIENCE
- Mesothelin targeted cancer immunotherapy
- (2007) Raffit Hassan et al. EUROPEAN JOURNAL OF CANCER
- Chemotherapy and tumor immunity: an unexpected collaboration
- (2007) Leisha et al. Frontiers in Bioscience-Landmark
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation